And HSPH1 was highly expressed in different tumors, such as colorectal cancer, B-cell lymphoma, melanoma and esophageal squamous cell carcinoma (31–34), while NAA25 knockdown could upregulate IFIT2 and NDRG1 expression and downregulate HSPH1 expression (Figure 3F). Here, NAA25 is linked to B-cell non-Hodgkin lymphoma.